OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
San Francisco, Calif. Aug. 23, 2004 To most people in the developed world, diarrhea is a nuisance. It means some discomfort and maybe a trip to the local pharmacy. However, many would be shocked to learn that it is one of the leading causes of death among the developing world's children, responsible for approximately two million deaths each year. Even more shocking, diarrhea contributes to t...Institute for OneWorld Health nominated for the 2004 World Technology Awards
San Francisco, Calif. Aug. 16, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., announced today that it has been nominated for this year's World Technology Awards in the category of Health & Medicine. The award is sponsored by the World Technology Network (WTN) and held in association with Nasdaq, Microsoft, TIME magazine, magazine, and CNN. ......Institute for OneWorld Health receives Gates Foundation grant
San Francisco, Calif. July 13, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., announced today it has received a $1.4 million grant from the Bill & Melinda Gates Foundation to support development of a vaccine for the prevention and treatment of malaria, including for infants and children in the developing world. ...... Globally, more than 300 m...OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
San Francisco, Calif. June 7, 2004 The economics and traditional structure of drug development are shifting in ways that could lead to viable markets for new, affordable drugs in the developing world if biopharmaceutical companies considered innovative collaborations with nonprofits, according to Victoria Hale, Ph.D., founder and CEO of the Institute for OneWorld Health, the first nonprofit pha...Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
Victoria Hale, founder and CEO of the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., will speak at the BIO 2004 Annual International Convention in the Global Health track during a breakout session titled Mutually Inclusive: New and Affordable Drugs for Developed, Developing Worlds. ...... The session will highlight how a collaboration among industry, new n...OneWorld Health completes enrollment, treatment in Phase III India trial
San Francisco, Calif. May 18, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., announced today it has completed enrollment and treatment of 667 patients in India suffering from visceral leishmaniasis (VL), a deadly parasitic disease also known as kala azar. Funded largely by the Bill & Melinda Gates Foundation, the largest Phase III clinical trial...Institute for OneWorld Health CEO advocates focus first on developing world markets
Berkeley, Calif. May 11, 2004 New biotech processes are poised to change the economics of manufacturing drugs, creating the potential for delivering both affordable medicines to patients in the developing world and laying the foundation for new markets, according to Victoria Hale, Ph.D., CEO of the Institute for OneWorld Health. The founder of the first nonprofit pharmaceutical company in the U...OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health
San Francisco, Calif. Mar. 30, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., today announced its intent to develop a volunteer network of corporate and industry pharmaceutical scientists that would promote development of medicines for neglected diseases. The news was announced upon receipt of a grant from the Sapling Foundation (Woodside, Cali...UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
(Santa Barbara, Calif.) The University of California, Santa Barbara announced today that it has donated all rights to a patent that covers the novel use of an established class of cardiovascular medicines as a potential new drug against a global parasitic disease. The Institute for OneWorld Health, a nonprofit pharmaceutical company based in San Francisco, will use the UCSB discovery and the we...Victoria Hale of Institute for OneWorld Health Named Fellow by International Women's Forum
The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, today announced that CEO Victoria Hale, Ph.D., has been named a Leadership Foundation Fellow for 2003-2004. Hale is one of 14 women selected from a field of more than 50 finalists from all over the world. She is founder and CEO of OneWorld Health, whose experienced team of pharmaceutical scientis...